# Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

> **NCT00542594** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 1840 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00542594
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 1840 (ACTUAL)
- **Why stopped:** No results are avaialble as the study did not complete according to the protocol
- **Last updated:** 2013-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00542594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00542594, "Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00542594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*